S&P Removes Pershing Square from CreditWatch Negative as Valeant (VRX) Stabilizes
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/27/2026
- Wall Street stocks end tad lower after hot inflation data ahead of Nvidia earnings
- Nvidia forecasts 70% sales growth next year, signals AI spending boom has years left to run
- Oil settles down after choppy session as investors weigh Hormuz talks
- Meta to pay up to $16.68 billion in mass social media settlement
- Anthropic agrees to $45bn cloud computing deal with Nscale - report
- Nutanix (NTNX) Tops Q4 EPS by 11c, Beats in Revenue; Offers Q1 Revenue Guidance
- Boston Scientific discloses cybersecurity incident causing global disruption
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
- FDA approves Revolution Medicines pancreatic cancer drug Rasonque
- NVIDIA (NVDA) Tops Q2 EPS by 14c, Offers Guidance
Valeant Pharma (VRX) Shares Squeeze to Session Highs
July 6, 2016 12:24 PM EDTValeant Pharma (NYSE: VRX) shares continue to power higher Wednesday. The stock is up well over 8.5 percent with robust volume.
Notably, short interest was at 32.6 million shares, or 9.8 percent of float, at the middle of last month. That was an... More
